Credit Suisse Ag Dexcom Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Dexcom Inc stock. As of the latest transaction made, Credit Suisse Ag holds 1,916,217 shares of DXCM stock, worth $149 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,916,217

Previous 1,958,321 2.15%

Holding current value

$149 Million

Previous $243 Million 9.37%

% of portfolio

0.26%

Previous 0.24%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$114.22 - $140.1 $4.81 Million - $5.9 Million	-42,104 Reduced 2.15%	1,916,217 $266 Million
Q4 2023 Feb 08, 2024	SELL	$75.49 - $124.16 $28.3 Million - $46.5 Million	-374,414 Reduced 16.05%	1,958,321 $243 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $27.2 Million - $43.6 Million	316,324 Added 15.69%	2,332,735 $218 Million
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $32 Million - $37.2 Million	-284,342 Reduced 12.36%	2,016,411 $259 Million
Q1 2023 May 10, 2023	SELL	$104.0 - $122.92 $23.7 Million - $28 Million	-227,660 Reduced 9.0%	2,300,753 $267 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $41.8 Million - $60.3 Million	-491,429 Reduced 16.27%	2,528,413 $286 Million
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $3.41 Million - $4.21 Million	44,655 Added 1.5%	3,019,842 $243 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $154 Million - $301 Million	2,263,186 Added 317.86%	2,975,187 $222 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $3.59 Million - $4.96 Million	-38,119 Reduced 5.08%	712,001 $364 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $32.9 Million - $41.2 Million	-253,049 Reduced 25.22%	750,120 $403 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $27.4 Million - $36.7 Million	-256,379 Reduced 20.35%	1,003,169 $549 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $4.52 Million - $6.02 Million	-55,821 Reduced 4.24%	1,259,548 $538 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $11.2 Million - $13.8 Million	132,197 Added 11.17%	1,315,369 $473 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $31.5 Million - $42.2 Million	404,084 Added 51.87%	1,183,172 $437 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $10.6 Million - $12.5 Million	110,602 Added 16.55%	779,088 $321 Million
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $4.43 Million - $7.44 Million	-70,667 Reduced 9.56%	668,486 $271 Million
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $2.09 Million - $3.3 Million	-43,643 Reduced 5.58%	739,153 $199 Million
Q4 2019 Feb 12, 2020	SELL	$36.62 - $57.29 $7.45 Million - $11.7 Million	-203,572 Reduced 20.64%	782,796 $171 Million
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $5.32 Million - $6.56 Million	-149,781 Reduced 13.18%	986,368 $147 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $497,695 - $695,772	17,877 Added 1.6%	1,136,149 $170 Million
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $5.24 Million - $7.12 Million	-186,502 Reduced 14.29%	1,118,272 $133 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $6.77 Million - $9.37 Million	250,830 Added 23.8%	1,304,774 $156 Million
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $1.7 Million - $2.67 Million	-72,638 Reduced 6.45%	1,053,944 $151 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $13 Million - $18.7 Million	-743,315 Reduced 39.75%	1,126,582 $107 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $5.53 Million - $7.86 Million	423,800 Added 29.31%	1,869,897 $139 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $4.99 Million - $6.9 Million	448,915 Added 45.02%	1,446,097 $83 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $4.02 Million - $6.72 Million	354,008 Added 55.04%	997,182 $48.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	643,174	643,174 $47 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account